stoxline Quote Chart Rank Option Currency Glossary
  
Azenta, Inc. (AZTA)
28.3  1.53 (5.72%)    05-12 16:00
Open: 28.23
High: 28.96
Volume: 1,204,695
  
Pre. Close: 26.77
Low: 28.04
Market Cap: 1,293(M)
Technical analysis
2025-05-12 4:46:07 PM
Short term     
Mid term     
Targets 6-month :  35.49 1-year :  41.45
Resists First :  30.38 Second :  35.49
Pivot price 26.5
Supports First :  26.38 Second :  23.9
MAs MA(5) :  26.69 MA(20) :  26.34
MA(100) :  41 MA(250) :  46.16
MACD MACD :  -1.4 Signal :  -2.1
%K %D K(14,3) :  81.9 D(3) :  66.9
RSI RSI(14): 49.8
52-week High :  63.58 Low :  23.9
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ AZTA ] has closed It is unclear right now based on current values. 57.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 9 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 28.99 - 29.19 29.19 - 29.35
Low: 27.66 - 27.88 27.88 - 28.04
Close: 28.02 - 28.35 28.35 - 28.61
Company Description

Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and handling; consumables; and instruments that help customers in managing samples throughout their research discovery and development workflows. The Life Sciences Services segment provides comprehensive sample management programs, integrated cold chain solutions, informatics, and sample-based laboratory services to advance scientific research and support drug development. This segment's services include sample storage, genomic sequencing, gene synthesis, laboratory processing, laboratory analysis, biospecimen procurement, and other support services. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Chelmsford, Massachusetts.

Headline News

Sun, 11 May 2025
Azenta to Participate in the UBS MedTech, Tools and Genomics Summit 2023 - Seeking Alpha

Fri, 09 May 2025
AZTA Q1 Earnings Call: Revenue Tops Expectations, Margin Progress Amid Macro Headwinds - FinancialContent

Thu, 08 May 2025
Azenta, Inc. (NASDAQ:AZTA) Q2 2025 Earnings Call Transcript - Insider Monkey

Thu, 08 May 2025
Azenta Inc (AZTA) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Macroeconomic ... - Yahoo

Wed, 07 May 2025
Azenta (AZTA) Price Target Lowered by Needham to $40 | AZTA Stock News - GuruFocus

Wed, 07 May 2025
Azenta Reports Second Quarter Results for Fiscal 2025, Ended March 31, 2025 - Quantisnow

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Instruments & Supplies
Shares Out 46 (M)
Shares Float 40 (M)
Held by Insiders 1.6 (%)
Held by Institutions 113.5 (%)
Shares Short 4,910 (K)
Shares Short P.Month 4,350 (K)
Stock Financials
EPS -0.98
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 37.16
Profit Margin -9.8 %
Operating Margin -8.8 %
Return on Assets (ttm) -1.7 %
Return on Equity (ttm) -8.6 %
Qtrly Rev. Growth -9.9 %
Gross Profit (p.s.) 6.1
Sales Per Share 14.61
EBITDA (p.s.) 0.38
Qtrly Earnings Growth 0 %
Operating Cash Flow 72 (M)
Levered Free Cash Flow 41 (M)
Stock Valuations
PE Ratio -29.18
PEG Ratio 0
Price to Book value 0.76
Price to Sales 1.93
Price to Cash Flow 17.96
Stock Dividends
Dividend 0.1
Forward Dividend 0
Dividend Yield 0.3%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android